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Neurosurgical treatment for psychiatric disorders features a long and 
controversial history. This article explores a “spectrum of psychosurgery”, 
describing how old-fashioned and controversial prefrontal lobotomy 
gradually evolved into modern day, mainstream scientific deep brain 
stimulation (DBS). We focus on the rise, fall and possible re-emergence 
of psychosurgery as a therapeutic intervention today. We journey through 
historic indiscriminate use of prefrontal lobotomy, which evoked stern 
criticism from both public and professionals, through to the development of 
modern day DBS - performed for patients suffering from severe, treatment 
resistant symptoms of obsessive-compulsive disorder (OCD), epilepsy 
and movement disorders. We hope this article will provide a basis for 
understanding the availability of existing treatment options and potential 
future opportunities, whilst simultaneously challenging any public/
professional preconceptions of psychosurgery, which may indirectly be 
obstructing patient care. Additionally, we carried out a qualitative survey 
displayed in WordCloud Format, capturing the intellection of 38 mental 
health professionals working for North West Boroughs NHS Healthcare 
Foundation Trust, on “psychosurgery”, “prefrontal lobotomy” and “DBS”, 
which may well reflect wider public opinion. In summary, the article 
provides a brief, yet comprehensive overview of the controversial history 
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1. Introduction
Psychosurgery...what comes to your mind when you
hear this word?
Extraction of the Stone of Folly (c.1450-1516)
Figure 1. Extracting the Stone of Madness [45]
Does it bear resemblance to this portrayed image? Do 
words like “barbaric”, “zombie” or “inhumane” spring to 
mind? Or perhaps the idea that it is useless and illegal? 
Neurosurgery for psychiatric disorders has relished 
enthusiastic support as well as facing scorn throughout 
human history. Any discussion unvaryingly evokes con-
troversy due to its indiscriminate use in the mid-twentieth 
century, resulting in profound ethical implications that 
remain to this day. Currently, the standard therapeutic 
approach to most psychiatric diseases involves either 
(or a combination of) psychotherapy, pharmacotherapy, 
and electroconvulsive therapy (ECT) in some cases. De-
spite these treatment methods, many patients still fail to 
respond effectively and continue to remain severely dis-
abled. Most patients and their families are unaware that 
such “last-resort” options like psychosurgery still exist. 
In intractable cases, surgical intervention may be consid-
ered suitable if the therapeutic result and overall level of 
functioning could be enhanced [3]. 
Interestingly there is evidence of brain surgery suc-
cessfully treating “organic” disorders such as epilepsy. 
According to a survey by physicians at Henry Ford Hospi-
tal, brain surgery for otherwise hard to treat epilepsy was 
found be an effective treatment for up to 15 years. Most 
prior studies had solely looked at seizure control and psy-
chosocial outcomes at 2-5 years post-surgery [42].
Such procedures for “organic” brain disorders are just 
as invasive and associated with similar risks as psycho-
surgical techniques for “functional” illnesses, however we 
suspect that its evolution has been far less controversial - 
why?
This article explores a “spectrum of psychosurgery”, 
describing how old-fashioned and controversial prefrontal 
lobotomy gradually evolved into modern day, mainstream 
scientific deep brain stimulation. It also explores the 
perceptions of medical professionals on psychosurgery, 
which may reflect wider public opinion and stigma. To 
explore this we asked a group of 38 psychiatrists and psy-
chiatry trainees working for North West Boroughs NHS 
Healthcare Foundation Trust, to write down 3 words re-
flective of their intellection about “psychosurgery (Figure 
4), prefrontal lobotomy (Figure 2), and deep brain stim-
ulation (Figure 10)”. We have displayed their responses 
visually as word clouds below, embedded into sections of 
relevant discussion, with the size of the font directly cor-
responding with the frequency of responses. 
2. A Spectrum of Psychosurgery from Pre-
frontal Lobotomy to DBS
2.1 Prefrontal Lobotomy Word Cloud
Figure 2. NWBH 38 psychiatrists “3 word” response to 
“Prefrontal lobotomy” [46]
The earliest evidence of psychosurgery has its roots in the 
Neolithic era of the stone age (around 5100 BC) [4]. During 
this period, numerous skulls were identified with areas of 
trephination and evidence of proper healing. The estimated 
long lifespan of these individuals, suggests that these early 
procedures were likely performed with therapeutic intent, 
rather than a traumatic origin of the wound [5]. It has been 
hypothesized that early trephination was performed for 
ritualistic or spiritual purposes, with intent to treat man-
ifestations of headaches, epilepsy, and mental illness [6]. 
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Figure 3. Skull showing holes made by trephination 
process - clearly begun to heal, suggesting that although 
highly dangerous, the procedure was by no means fatal [47]
In the early 1800s, new insights into functional neuro-
anatomy and neurophysiology stimulated renewed interest 
into psychosurgery. In 1819, Franz Joseph Gall published 
his treatise on phrenology, which suggested that the brain 
possessed discrete functional regions [7]. He divided the 
brain into sections that corresponded to certain behaviours 
and traits that he called fundamental faculties. He based 
his structure-function association primarily on cranial dif-
ferences between men and women [8].
Despite the idea of phrenology being flawed and even-
tually disgraced, Paul Broca and Carl Wernicke stretched 
the idea of neurological functions having an anatomical 
link in seminar work. This notion was further expanded 
by work of Gustav Fritsch, Eduard Hitzig, and David Fer-
rier on localization of the motor cortex [6].
When discussing traumatic brain injury, it is pertinent 
to recall the famous case of Phineas Gage, an American 
railroad construction worker, who developed personality 
changes (aggressive and impulsive behaviour, along with 
the defect in rational decision making and emotions pro-
cessing) following an accidental penetrating injury to his 
left frontal lobe [9]. 
A Swiss psychiatrist named Gottlieb Burckhardt, per-
formed the first psychosurgical procedures as early as 
1888, after gaining inspiration from Phineas Gage’s case 
findings. He conducted these procedures on six chronic 
schizophrenic patients and excised their cerebral corti-
ces, which was thought to be responsible for aggression, 
agitation and hallucinations. Most patients showed im-
provement and became easier to manage, although one 
patient died from the procedure and some had aphasia 
or seizures [10]. He published his findings in 1891 in a 
scholarly paper; however, his approach outraged the med-
ical community, calling him ruthless and irresponsible. 
This led to cessation of his academic endeavours [11]. The 
research and quest of psychosurgery became invisible 
until 1935, when Yale psychologists John Fulton and Car-
lyle Jacobsen presented a study on frontal lobectomy in 
primates and described the role of the frontal lobe in short 
term memory, anxiety and aggression [12].
2.2 Psychosurgery Word Cloud
Figure 4. 38 psychiatrists “3 word” response to “Psycho-
surgery” [48]
Egas Moniz, a Portuguese neurologist, along with neu-
rosurgeon Almeida Lima developed a procedure called 
leucotomy (lobotomy) for the treatment of psychiatric 
patients with prominent depression, anxiety or aggression. 
The first lobotomy was performed on November 12th, 
1935 by Almeida Lima, on the orders of Egas Moniz [13]. 
Their patient was a psychotic woman in her sixties, and 
Lima treated her by piercing her skull with a bone drill 
and killing frontal lobe brain tissue with an injection of 
alcohol. Moniz called this procedure a “prefrontal leucot-
omy” [14]. Between November 1935 and February 1936, 
Moniz and Lima performed lobotomies on nineteen more 
patients [15].  During this time, they revised their surgical 
technique and began using an instrument called a leuco-
tome to destroy tissue in the frontal lobes [16]. Leucotomy 
had the best results on patients with agitated depression 
and involutional melancholia, the majority of whom 
Moniz classed as “greatly improved” [17].  Moniz and Lima 
also discovered that the procedure did not remove the 
symptoms of psychosis or improve obsessive-compulsive 
symptoms, much like other therapies. However, Moniz 
considered the operation to be an overall success, since 
patients became calm and were often discharged from 
hospital [18]. 
Leucotomy was introduced into the United States in 
1936 by the neurologist Walter Freeman and the neuro-
surgeon James Watts [19]. They performed their first oper-
ation on September 14th, 1936. The patient, “A.H.”, was a 
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middle-aged woman with severe agitated depression [20]. Al-
though Freeman noted that the long-term effects of frontal 
lobe damage were unknown, the patient was “relieved” 
of her agitation and depression. Freeman and Watts orig-
inally used Moniz’s leucotomy technique before altering 
it to develop the standard lobotomy. This was a blind pro-
cedure which involved drilling into the skull near the top 
of the forehead, and then using a cannula (a sharp-ended 
tube) and leucotome to make “sweeping motions” and 
“stab incisions”. This was done on both sides of the head 
with the patient potentially still awake [21,22]. This advanced 
procedure was termed the prefrontal lobotomy. Minimal 
lobotomies were mainly performed for the treatment of 
affective symptomatology, while radical lobotomies were 
for schizophrenic patients or those with refractory symp-
toms [23].
Figure 5. Transorbital Lobotomy Procedure [49]
Between January and March of 1946, Freeman began 
performing “transorbital” or “ice-pick” lobotomies. This 
process involved destroying frontal lobe tissue by moving 
around a cannula that was inserted into the brain through 
the bony orbit above the eye (Figure 5) [24]. Transorbital 
lobotomy destroyed less total brain tissue than the stan-
dard prefrontal leucotomy, and, according to Freeman, 
did not produce any “significant intellectual or personality 
deficits”. Freeman promoted the transorbital approach as 
a “safe, simple, and quick” minor operation that merely 
required electroshock therapy for sedation. Hence psy-
chiatrists could perform this without a neurosurgeon, 
anaesthetist or even proper sterile technique [25].  By 1952, 
when anti-psychotic drugs were introduced as a psychiat-
ric treatment, Freeman and Watts had performed over 600 
surgeries [26]. 
Figure 6. Lobotomy Tool Set consisting of a Hammer and 
Orbitoclast [50]
Figure 7. Dr Walter Freeman performing a transorbital 
lobotomy [51,52]
Leucotomy was gradually introduced in Britain in 
1941 and was used more rapidly after World War II. By 
November 1961, 15,000 or more patients had reportedly 
received the operation [27].  Even before the introduction of 
chemical treatments in the early 1950s, leucotomy num-
bers slowed down nationally, possibly due to adverse side 
effects [28]. 
Figure 8. A CAT scan of a brain after leucotomy. The 
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Ultimately, the opinion of professionals and public 
turned against the lobotomy owing to the link of morbid-
ity and mortality becoming more obvious [22]. A number 
of patients developed symptoms like apathy, emotional 
blunting, and disinhibition; which was jointly named as 
“post-leucotomy syndrome”. Consequently, the medical 
association instigated to obtain further scientifically rig-
orous surgical methodologies, which were focused on 
hypothesis-driven targeting, with less hostile wounds and 
resections. 
Due to the early enthusiasm for frontal lobe lobotomy 
and its widespread social acceptance, the non-neurosur-
geons started performing this procedure in inappropriate 
settings. This sparked professional criticism regarding the 
substantial underreported adverse events, along with the 
lack of scientific rigor [29]. Additionally, the public became 
conscious of the objectionable consequences of lobot-
omies; and social attitudes were moulded by damaging 
portrayals in literature and film, including noteworthy ex-
amples such as One Flew Over the Cuckoo’s Nest. It also 
came to the light that some institutionalized or incapaci-
tated patients had lobotomies done without their informed 
consent, and that it may have been performed on prisoners 
to tackle dysfunctional behaviour rather for treating men-
tal illness [23].
Ultimately, it was the growth of pharmacotherapy that 
turned the tide against psychosurgery, predominantly with 
the arrival of lithium [30] and chlorpromazine [31]. Although, 
electroconvulsive therapy (ECT) was also initiated before 
the arrival of psychotropics, and was documented as being 
efficacious in the treatment of psychiatric disorders, its 
use had also dramatically shrunken before 1980s, due to 
its side effects on cognition and memory [32]. 
However despite psychotropics, psychotherapies and 
ECT interventions, it became clear that a significant num-
ber of patients were not responding to these treatments, 
and psychosurgery was either being overlooked or not 
considered at all.
The success of the cardiac pacemaker, gave the public 
“the notion of an implantable device legitimacy and ap-
peal” [43], and the subsequent development of present-day 
deep brain stimulation (DBS) is largely attributed to Alim 
Benabid. In the late 1980s, he discovered that the symp-
toms of Parkinson’s disease improve massively following 
electrical stimulation of basal ganglia [33]. This neurosurgi-
cal procedure involved the placement of a neurostimulator 
(sometimes referred to as a “brain pacemaker”), which 
sent high-frequency electrical impulses through implanted 
electrodes deep in the brain, to specific brain areas respon-
sible for the symptoms of each disorder [34]. 
Deep brain stimulation emerged as a neurosurgical 
treatment modality from ablative stereotactic neurosur-
gery. It nearly became extinct following the introduction 
of antipsychotics for psychiatric disorders and levodopa 
for Parkinson’s disease. However, it soon became clear 
that a suggestive number of patients either had intolerable 
side effects or inadequate response to pharmacotherapy, 
which gave credence for consideration of invasive surgi-
cal interventions like deep brain stimulation in patients 
suffering significant functional impairment.
Figure 9. Deep Brain Stimulation procedure [54]
Today DBS is used in a variety of conditions. It is 
currently approved by the U.S. Food and Drug Admin-
istration (FDA) to treat refractory Parkinson’s disease, 
primary dystonia, intractable seizures, essential tremors 
and chronic cluster headaches [35]. The use of DBS in Par-
kinson’s disease and essential tremor has proved so effec-
tive that it has been licensed as a treatment option [36]. This 
well-known procedure has now been used for more than 
20 years, and despite the invasive nature, it is linked with 
minimal adverse effects. 
DBS has also successfully treated patients suffering 
from various intractable psychiatric disorders. Severe, 
treatment-resistant obsessive-compulsive disorder (OCD) 
is a chronic, incapacitating disorder, imposing substantial 
suffering and significantly impairing affected individuals’ 
ability to work, interact socially, or live independently. 
DBS drastically reduces the symptoms of severe OCD, by 
stimulating either Ventral Capsule (VC) or anteromedial 
subthalamic nucleus (amSTN), according to a study in Bi-
ological Psychiatry [38].
Furthermore, DBS has emerged as a prospective option 
for select Tourette syndrome patients whose motor and/
or vocal tics impact the quality of life ominously, despite 
maximal use of other treatment options. The implantation 
of electrodes in three target areas (nucleus accumbens as 
part of the ventral striatum, globus pallidus internus and 
thalamus), all of which have proved effective [39]. 
An interesting study was published in the American 
Journal of Psychiatry on Friday October 4 2019, which 
found that deep brain stimulation of subcallosal cingulate 
DOI: https://doi.org/10.30564/jgm.v1i3.1943
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(SCC) area in the brain provides a robust antidepressant 
effect, that is sustained over a long period of time in pa-
tients with treatment-resistant depression [40]. New findings 
were made by a team of researchers led by Dr. Andres 
Lozano at the Krembil Neuroscience Centre (KNC) of 
Toronto Western Hospital (TWH). They provided further 
insight into the effects of Deep Brain Stimulation in the 
treatment of Alzheimer’s disease [41].
3. Deep Brain Stimulation  WordCloud
Figure 10. 38 psychiatrists “3 word” response to “Deep 
Brain Stimulation” [55]
4. Qualitative Survery of North West Bor-
oughs Healthcare (NWBH) professionals re-
garding “Psychosurgery”, “Prefrontal lobot-
omy” and “Deep Brain Stimulation”
We conducted a survey at NWBH NHS healthcare foun-
dation trust, capturing the intellection of 38 mental health 
professionals. The survey was done in joint academic 
round, and 3 separate survey papers were distributed, 
with professionals asked to write 3 words that come to 
their minds when they heard the terms “psychosurgery”, 
“prefrontal lobotomy” and “deep brain stimulation”. Two 
minutes were provided, in order for instinctive conscious/
unconscious responses to be recorded. The survey papers 
were then collected, and the results are displayed using 
word cloud format (Figure 4,2 & 10). The larger the font, 
the more popular that word response was.
5. Conclusion
The results of our survey demonstrated that 38 NWBH 
professionals commonly viewed Psychosurgery as “bar-
baric, controversial, extreme”, and prefrontal lobotomy as 
“barbaric, cruel and outdated”, amongst other responses.
Deep Brain Stimulation was viewed in a somewhat 
more favourable positive light, with common responses 
being “innovative, futuristic and associated with treatment 
for depressive and Parkinson’s disease”. 
Why was this? 
Was it because the clinicians thought that the emer-
gence of better scientific evidence and neuroimaging tech-
niques to guide such procedures makes DBS safer? 
We found these results interesting, as DBS is still a 
significantly invasive procedure. DBS still involves drill-
ing holes into to the skull, with invasive electrodes being 
implanted on (usually) both sides of the brain. Such pro-
cedures are no less likely to cause complications such as 
bleeding and/or infection.
We also suspect that the use of brain surgery for “or-
ganic” brain disease has been far less controversial than 
for “functional” brain disorders? If so, then why? 
The NHS Commissioning Board (NHS CB) commis-
sions Deep Brain Stimulation for patients with Parkin-
son’s disease, tremor and dystonia in accordance with the 
eligibility criteria [44]. Presently, we don’t see this happen-
ing for functional disorders. Why is this? These are the 
questions which began surfacing in our minds whilst writ-
ing this article. 
Our take home message is that as clinicians we must 
examine, unpick and confront any possible preconceptions 
and cognitive bias in our conscious/unconscious minds 
regarding psychosurgery, as we are potentially denying 
patients suffering from distressing intractable symptoms a 
viable treatment option.
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MCQ’s
1. Burckhardt performed the first psychosurgical proce-
dures on patients suffering from which psychiatric disor-
der?
(1) Depression
(2) Obsessive Compulsive Disorder
(3) Schizophrenia
(4) Epilepsy
2. The first prefrontal leucotomy technique was carried 
out by which technique?
(1) Killing frontal lobe tissue with an injection of alco-
hol
(2) Killing frontal lobe tissue with a leucotome instru-
ment
(3) Killing frontal lobe tissue with an ice pick
(4) Killing frontal lobe tissue with an injection of acid.
3. Which noteworthy film may have contributed to 
moulding of social attitudes to lobotomies?
DOI: https://doi.org/10.30564/jgm.v1i3.1943
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(1) A Beautiful Mind
(2) Shutter Island
(3) The Snake Pit
(4) One Flew Over The Cuckoo’s Nest.
4. The arrival of which two drugs turned the tide 
against psychosurgery?
(1) Haloperidol and Promazine
(2) Lithium and Chlorpromazine
(3) Imipramine and Thorazine
(4) Valium and Prozac
5. Which of the following conditions is Deep Brain 
Stimulation (DBS) not approved by the US FDA (Food & 
Drug Administration) for ?
(1) Parkinson’s disease tremor
(2) Chronic Cluster headache
(3) Intractable Epilepsy
(4) Borderline Personality Disorder
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